Fertility Startup Gameto Raises $44 Million to Test Egg-Freezing Therapy in US
Gameto Inc., a biotech company working on stem-cell therapies for women’s health, has raised $44 million in venture capital to help fund a clinical trial for its product that aims to improve the egg-freezing experience.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
